Trials / Withdrawn
WithdrawnNCT00747032
To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis
Multi-Center, Double-Blind, Randomized, Vehicle-controlled, Parallel-Group Study Comparing NYC-0462 Ointment To a Vehicle Control
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Fougera Pharmaceuticals Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this trial is to assess the efficacy of NYC-0462 Ointment in the Treatment of Plaque Psoriasis.Treatment medication will be administered as follows: A thin layer of study product will be applied to the affected skin, excluding the face, once daily, at approximately the same time daily.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NYC 0462 Ointment | To assess the efficacy of NYC 0462 Ointment versus Placebo in the treatment of Plaque Psoriasis |
| DRUG | Placebo | To assess the efficacy of NYC 0462 Ointment versus Placebo in the treatment of Plaque Psoriasis |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-02-01
- Completion
- 2011-04-01
- First posted
- 2008-09-04
- Last updated
- 2012-05-07
Source: ClinicalTrials.gov record NCT00747032. Inclusion in this directory is not an endorsement.